Mesoblast PE Ratio Insights

Mesoblast Ltd (MESO)

12.08 +0.32 (+2.72%) USD | NASDAQ | Dec 16, 15:51

PE Ratio Chart

View PE Ratio for MESO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Cumulative Total Returns Versus Peers

Start Trial

Historical Data

View Historical Data

Start Trial

Price to Earnings Ratio (PE Ratio) Definition

View Price to Earnings Ratio (PE Ratio) Definition

Start Trial

The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.

Read full definition.

PE Ratio Range, Past 5 Years

View PE Ratio Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

PE Ratio Benchmarks

View PE Ratio Benchmarks

Start Trial

Alterity Therapeutics Ltd	--
Kazia Therapeutics Ltd	--
Immutep Ltd	--
Opthea Ltd	--
Immuron Ltd	--

PE Ratio Related Metrics

Price	12.08
Market Cap	1.379B